Cite

HARVARD Citation

    Son, J. et al. (n.d.). 2022-RA-262-ESGO Predictors of oncologic outcome in recurrent cervical cancer patients receiving phase 1 cancer therapy. International journal of gynecological cancer. pp. A6-A7. [Online]. 
  
Back to record